The influence of Zusanli point acupuncture with Neostigmine in restoring the gastrointestinal function of the patients after abdominal surgery

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-14005340

Enrollment

Unknown

Registered

2013-11-01

Start date

2013-12-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastrointestinal disorders

Interventions

A:Neostigmine point injection

B:Saline point injection

C:No treatment

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Range of age from 18 yrs to 75 yrs; no limitation to gender; after open abdominal or laparoscopic surgery; Informed consent obtained from patients or their appointed agent.

Exclusion criteria

Exclusion criteria: Hypersensitivity to anticholinesterases and bromides; mechanical intestinal or urinary obstruction; peritonitis; angina pectoris; ventricular tachycardia; pregnant woman and woman during lactation; patients with mental sickness;taking part in other clinical trials.

Design outcomes

Primary

Measure	Time frame
the time of first passing flatus;the time of the first observed passage of stool;the time that the patients tolerated a solid diet;tithe time to walk independently;duration of hospital stay;VAS;	—

Contacts

Public ContactHua Yang

hwbyang@126.com+86 23 68755705

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026